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Apolipoprotein E-receptor-mediated pathways are the main routes by which macrophages take up chylomicron remnants, but
uptake may also be mediated by receptor-independent routes. To investigate these mechanisms, triacylglycerol (TG) accumulation
induced by apolipoprotein-free chylomicron remnant-like particles (CRLPw/o) in human monocyte-derived macrophages was
evaluated. Macrophage TG content increased about 5-fold after incubation with CRLPw/o, and this eﬀect was not reduced by the
inhibition of phagocytosis, macropinocytosis, apolipoprotein E function, or proteoglycan bridging. The role of lipases, including
lipoprotein lipase, cholesteryl ester hydrolase, and secretory (sPLA2) and cytosolic phospholipase A2, was studied using [3H]TG-
labelled CRLPw/o. Total cell radioactivity after incubation with [3H]TG CRLPw/o was reduced by 15–30% by inhibitors of
lipoprotein lipase and cholesteryl ester hydrolase and by about 45% by inhibitors of sPLA2 and cytosolic PLA2 . These results
suggest that macrophage lipolytic enzymes mediate the internalization of postprandial TG-rich lipoproteins and that sPLA2 and
cytosolic PLA2, play a more important role than extracellular lipoprotein lipase-mediated TG hydrolysis.
1.Introduction
Lipids from the diet are absorbed from the intestine in
chylomicrons, large triacylglycerol (TG)-rich lipoproteins,
which are secreted into lymph and pass into the blood via
the thoracic duct. The chylomicrons then undergo rapid
lipolysis by lipoprotein lipase (LPL) in extrahepatic capillary
beds, a process which removes some of the TG and leaves
smaller chylomicron remnants which deliver the remaining
dietary lipids to the liver [1]. It was believed for many
yearsthatchylomicronremnantsizepreventedtheirentrance
into the artery wall and their subsequent interaction with
macrophages. However, it is now clear that chylomicron re-
mnants can penetrate and be retained within the subendo-
thelialspaceaseﬃcientlyaslowdensitylipoprotein(LDL)[2,
3]. In addition, apolipoprotein-B48-containing lipoproteins
have been isolated from atherosclerotic plaques [4].
Chylomicron remnants have been shown to be taken up
by several types of macrophages and to cause extensive TG
and cholesterol accumulation leading to foam cell forma-
tion [5–8], further supporting the atherogenic role of this
lipoprotein. The pathways mediating macrophage uptake
of chylomicron remnants are apolipoproteinE (apoE)-
dependent receptor-mediated processes involving the LDL
receptor and the LDL receptor-related protein (LRP) [9–
11]. However, several studies have found evidence that
chylomicron remnant uptake pathways in these cells may
be independent of the LDL receptor [6, 12]a n da p o E
production[6].Furthermore,Fujiokaetal.[6]ha v er eport ed
that apolipoprotein-free remnant particles are taken up
and promote lipid deposition in macrophages from apoE-
deﬁcient mice [6]. Thus, it seems likely that there are non-
apoE-mediated receptor pathways which mediate the uptake
of apolipoprotein-free chylomicron remnants by human2 International Journal of Vascular Medicine
macrophages. The aim of this study was to investigate
these pathways and to evaluate whether secretory lipases are
involved in their function.
2.MaterialsandMethods
2.1. Materials. Glycerol-tri[9,10(n)-3H]oleate (28Ci/mmol),
[1(3)-3H]glycerol (60mCi/mmol), and [4-14C]cholesteryl-
oleate (60mCi/mmol) were obtained from NEN Life Sci-
ence Products Inc. Boston, Mass, USA. Iscove’s Modiﬁed
Dulbecco’s Medium (IMDM), fetal bovine serum (FBS),
Ficoll-Paque, penicillin, and streptomycin were obtained
from Hyclone Europe Ltd., CD14 MicroBeads and LS
Separation Columns were purchased from Miltenyi Biotech.
Goat antibody to human apoE and goat immunoglobulin
G (IgG) were obtained from Biodesign (Bologna, Italy).
Cytochalasin D, orlistat, brefeldin, manoalide, fatty acid-
free bovine serum albumin (BSA), phorbol 12-myristate 13-
acetate (PMA), heparinase I, heparinase III, MJ33, sodium
chlorate, and various classes of lipids and solvents were
purchased from Sigma Chemical Company (St. Louis, Mo,
USA). methyl arachidonyl ﬂuorophosphonate (MAFP) and
haloenol lactone suicide substrate (HELSS) were purchased
fromBiomolInternational(Vinci-Biochem,Vinci,Italy).For
lipid analysis of lipoprotein particles, enzymatic kits for the
determinations of total (TCH) and free cholesterol (FCH)
were obtained from WAKO (Test Medical, Zola, Italy) and
that for TG from BPC (Rome, Italy).
2.2. Macrophages. Monocytes were isolated from human
buﬀy coats as previously described [13]. Buﬀy coats from the
blood of healthy donors were diluted 1:3 with phosphate-
buﬀered saline (PBS) and layered on Ficoll-Paque. After
centrifugation, white blood cells were collected and washed
with PBS. CD14 MicroBeads were used for the positive
selection of human monocytes from white blood cells.
According to the manufacturer’s instructions, 300–400 ×106
total cells, magnetically labelled with CD14 MicroBeads,
were applied to LS Separation columns, and the total
eﬄuent was discarded. Monocytes (CD14-positive fraction),
ﬂushed out of the column, were washed, and 1.5 × 106
cells transferred to 22-mm dishes at a concentration of 8 ×
105 cells/mL and cultured in IMDM containing 15% FBS.
The purity of isolated monocytes, monitored by speciﬁc
ﬂow cytometric analysis for CD14, ranged 95–97%. The
diﬀerentiation process from monocytes to macrophages was
monitored by the increased expression of CD71 antigen.
The experiments were performed with human monocyte-
derived macrophages (HMDM) 10 days after plating. For
experiments involving the measurement of lipid accumula-
tion, CRLP were incubated with HMDM for 24h, so that
there was suﬃcient uptake to allow accurate determination
of TG and cholesterol in the cells. Shorter incubation times
(5-6h) were used for experiments involving radioactivity, as
these techniques are more sensitive.
Cultures of the J774.2 murine macrophage-like cell line
(J774) were obtained from the American Type Culture
Collection (Rockville, Md, USA). Cells were maintained in
DMEM supplemented with penicillin (100U/mL), strepto-
mycin (100μg/mL), glutamine (2mM), and 10% FBS at
37◦C in a humidiﬁed atmosphere of 95% air/5% CO2.F o r
experiments, cells (at passage 6–10) were seeded into 22-mm
dishes at a concentration of 105 cells/mL and used on the 3rd
day of culture.
2.3. Preparation of CRLP. Chylomicron remnant-like par-
ticles (CRLP) containing TG as the major lipid class were
prepared by sonication of a lipid mixture followed by
ultracentrifugation [14]. A lipid mixture containing 70%
triolein (18:1), 2% cholesterol, 3% cholesteryl ester, and
25% phospholipids (70.5% phosphatidylcholine, 11% phos-
phatidylethanolamine, 6.9% lysophosphatidylcholine, 6.5%
sphingomyelin, 2.6% phosphatidylinositol, and 2.6% phos-
phatidylserine) was sonicated in 0.9% NaCl in Tricine buﬀer
(20mM, pH 7.4) for 20min at 37◦C with a power giving an
amplitude range, quoted as total peak to peak moments of
22–24μm (Branson 250/450 soniﬁer). For the preparation
of CRLPw/o with labelled TG, before sonication, 100μCi
of glycerol-tri[3H] oleate ([3H]TG) was added to the lipid
mixture. After soniﬁcation, the density of the emulsion was
increased to 1.21g/mL with KBr, layered under a step-wise
density gradient and centrifuged at 17,000g for 20min at
20◦C. The upper layer was discarded and replaced with an
equal volume of KBr (d 1.006g/mL), and the centrifugation
was repeated at 70,000g for 1h at 20◦C. The particles
were harvested from the top layer, dialyzed against medium
without FBS, but containing penicillin/streptomycin. These
CRLP (CRLPw/o), which do not contain apolipoproteins,
were used for experiments within 2 days of their preparation.
For the preparation of lipid particles containing apoE
(CRLP+), CRLPw/o were incubated with human plasma as
previously described [13]. Previous analysis by SDS-PAGE
has shown that CRLP prepared in this way contain apoE and
no other apolipoproteins [11]. The band corresponding to
apoE was not detected in lipid particles prior to incubation
with plasma, nor in the top fraction from plasma centrifuged
in the absence of lipid particles, indicating that the CRLP
acquired apoE during the incubation.
2.4. Negative Staining Electron Microscopy of CRLP. Samples
weredilutedwithdistilledwatertoachieveasatisfactorycon-
centrationoflipidparticlesfornegativestaining.A200-mesh
nickel grid with a type-B carbon support ﬁlm (Ted Pella,
Redding, Calif, USA) was incubated with a drop of diluted
sample. After 10 minutes, the grid was drained with ﬁlter
paper and stained with 2% phosphotungstic acid (pH = 4)
for 2 minutes. The grid was drained and photographed with
a Jeol 1200 transmission electron microscope.
2.5. Cellular Assay of Cholesterol and TG. After incubations,
cells were washed 3 times with PBS and harvested from
wells by scraping into 500μL of distilled water. An aliquot of
cellular suspension was utilized to determine protein content
by Lowry’s method [15], using BSA as a standard. After the
extraction of cellular lipids [16], the TCH and TG content of
cells was determined by ﬂuorimetric methods according toInternational Journal of Vascular Medicine 3
Gamble et al. [17] and Mendez et al. [18], respectively. Each
determination was performed in duplicate.
2.6. Assay of TG Synthesis. Synthesis of TG and PL was
evaluated by determining the incorporation of [3H]glycerol
into TG and PL as previously described [13]. HMDM
w e r ei n c u b a t e df o r5 ha t3 7 ◦C in serum-free IMDM
containing 80μg cholesterol/mL CRLPw/o in the presence
of [3H]glycerol (4μCi/mL, 20μM). After the incubations,
HMDM were washed 3 times with PBS, and cell lipids
were extracted with hexane/isopropanol; 3:2, v/v. [14C]CE
was added as an internal standard and the lipids classes
were separated by thin layer chromatography on silica gel
(Merck, Germany) developed in hexane/ether/acetic acid
(70:30:1, v/v/v). Radioactivity associated with the bands
corresponding to [3H]TG and [3H]PL were scraped from the
plates and assayed for radioactivity in an LS5000 Beckman
liquid scintillation counter.
2.7. Statistical Methods. Repeated Measure Analysis of vari-
ance (ANOVA) and multiple comparisons using the Tukey-
Kramer Multiple Comparison Test or Student’s paired t-test
were used to evaluate signiﬁcant diﬀerences in the means
between groups. P < 0.05 was considered signiﬁcant.
3. Results
3.1. Characterization of CRLP. Biochemical characterization
of CRLPw/o and CRLP+ (Table 1) showed that CRLPw/o
and CRLP+ diﬀer in their TG/TCH (9.68 ± 2.88 versus
4.95 ± 2.30, respectively; P<0.005) and FCH/TCH (0.52 ±
0.30 and 0.21 ± 0.11, resp.; P<0.05) molar ratios. As
the TG concentration was not diﬀerent between CRLPw/o
(8.41 ± 2.9mM) and CRLP+ (7.42 ± 3.79mM), much of
the diﬀerence between the lipid ratios are attributable to a
decreased TCH content in CRLP-w/o in comparison with
CRLP+ (0.87 ± 0.57mM versus 1.79 ± 0.88mM, P < 0.005).
These changes in biochemical composition were accompa-
nied by diﬀerences in the size of the particles. The average
particle diameter determined from electron microscopy of
CRLPw/o (Figure 1(b)), and CRLP+ (Figure 1(a))w a s3 4
± 5nmand24± 7nm, respectively. Preparations of [3H]-
TG CRLPw/o produced particles with a speciﬁc activity of
2780 and 3810dpm/nmol of fatty acid in the 2 diﬀerent
preparations used for the 3 experiments. Radioactivity
distribution in the lipids carried by the particles was similar
in the 2 preparations. More than 90% of the radioactivity
carried by [3H]-TG CRLP was associated with TG, while the
radioactivity associated with PL, free fatty acids, cholesteryl
ester, and the sum of radioactivity recovered from the TLC
plate but not associated with these bands was 2.8, 2.1, 0.4,
and 4.7 %, respectively.
3.2.RoleofPlasma-DerivedFactorsinMacrophageLipidAccu-
mulationInducedbyCRLP. Toinvestigatetheroleofplasma-
derived factors in the induction of human macrophage
lipid accumulation by chylomicron remnants, we measured
macrophage TG and TCH of macrophages incubated with
(a)
100nm
(b)
Figure 1: Negative staining electron microscopy (EM). Negatively
stained CRLPw/o (b) and CRLP+ (a). The particle diameter
expressedasmean ±SDwas34 ±5nmforCRLPw/o(190particles)
and 24 ± 7nm for CRLP+ (160 particles).
e i t h e rC R L P +o rC R L P w / oi nc o m p a r i s o nt om a c r o p h a g e s
incubated without the lipid particles. The small consistent
increase (12%) of cell cholesterol (Figure 2(a)) induced by
CRLP+ (89.4 ± 4.5nmol/mg protein, n = 6; P<0.05
versus control w/o) in comparison with the control (79.1 ±
4.9nmol/mg protein), was not observed with CRLPw/o
(83.9 ± 7.4nmol/mg protein). The presence of CRLP+
inducedalmosta10-foldincreaseinTGmacrophagecontent
(47.8±15.8and464.3±190.2nmol/mgproteinintheabsence
or presence of CRLP+, resp.), and this was reduced to about
5 fold (226.3 ± 93.1nmol/mg protein), (Figure 2(b)), when
CRLPw/o particles lacking apolipoproteins were used. Thus,
the increase in macrophage TG content after incubation
with CRLPw/o remained substantially higher than the
control (P<0.05), indicating that CRLPw/o can induce
macrophage lipid accumulation independent of plasma-
derived apolipoproteins.
3.3. Role of Phagocytosis and Macropinocytosis in Macrophage
Internalization of CRLPw/o. Macrophages are professional
phagocytes which carry out two related uptake processes,
phagocytosis, and macropinocytosis [19], both of which
may be involved in atherosclerosis development [20, 21].4 International Journal of Vascular Medicine
Table 1: Biochemical characterization of chylomicron remnant-like lipid particles (CRLP) incubated without (CRLPw/o) or with plasma
(CRLP+). Total cholesterol (TCH), triacylglycerol (TG), and free cholesterol (FCH) are expressed as means ± SD (n).
TCH TG FCH TG/TCH FCH/TCH
(mM) (mM) (mM) (molar ratio) (molar ratio)
CRLPw/o 0.87 ± 0.57 (20)∗∗ 8.41 ± 2.90 (20) 0.45 ±0.21 (7) 9.68 ± 2.88 (20)∗∗ 0.52 ± 0.30 (7)∗
CRLP+ 1.79 ± 0.88 (5) 7.42 ± 3.79 (5) 0.38 ± 0.20 (5) 4.95 ± 2.30 (5) 0.21 ± 0.11 (5)
∗P < 0.05 versus CRLP+
∗∗P < 0.005 versus CRLP+.
Control CRLPw/o CRLP+
0
2.5
5
7.5
10
∗
∗∗
#
C
e
l
l
T
G
(
F
o
l
d
i
n
c
r
e
a
s
e
v
e
r
s
u
s
c
o
n
t
r
o
l
)
(a)
Control CRLPw/o CRLP+
∗
0
0.2
0.4
0.6
0.8
1
1.2
1.4
C
e
l
l
T
C
H
(
F
o
l
d
i
n
c
r
e
a
s
e
v
e
r
s
u
s
c
o
n
t
r
o
l
)
(b)
Figure 2: Eﬀect of plasma treatment of CRLP on macrophage lipid accumulation induced by CRLP. HMDM were incubated for 24h in
serum-free medium without the addition of CRLP (control) or with 80μg cholesterol/mL of either CRLP+ (contains apoE) or CRLPw/o
(lacks apoE). (a) Cellular TG; (b) total cholesterol (TCH) content was determined by ﬂuorimetric assay (mean ± SD, n = 6). Results are
expressed as increase of lipid content with respect to the control. ∗P < 0.05, ∗∗P < 0.001 versus control; #P < 0.05 versus CRLP+.
Phagocytosis and macropinocytosis can be blocked by
cytochalasin D, and macropinocytosis can be induced in
some macrophage phenotypes by treatment with phorbol
esters such as PMA [20]. Thus, we investigated the function
ofthesepathwaysonCRLPw/ouptakebyincubatingHMDM
with CRLPw/o 20μg (results not shown) or 80μg choles-
terol/mL) in the presence of cytochalasin D (2μg/mL), or
PMA (1μg/mL), or the vehicle alone (control). The results
(Figure 3) show that the changes in cellular TG and TCH
content caused by CRLPw/o were not modiﬁed by cytocha-
lasin D or PMA, suggesting that, over the concentration
range of CRLP tested, phagocytosis and macropinocytosis
are not directly involved in CRLPw/o-induced macrophage
lipid accumulation.
3.4. Eﬀect of Inhibition of Macrophage Secretion on TG Accu-
mulation. Macrophages display a wide range of functions
and secrete many factors potentially aﬀecting lipoprotein
metabolism (i.e., apoE and lipases) that could mediate
uptake of CRLPw/o. To evaluate if factors secreted by
macrophages contribute to the internalization of CRLPw/o,
we added CRLPw/o (80μg cholesterol/mL) to macrophages
that had been preincubated for 3h with 0 (control), 5 and
15μg/mL brefeldin, an early stage inhibitor of the secretory
pathway [22]. Incubation was then continued for 24h in
the presence of brefeldin. Macrophage TG content (542 ±
142nmol TG/mg protein in the absence of brefeldin) was
signiﬁcantly (P < 0.05, n = 6) reduced by about 39% and
31%, respectively, by 5 and 15μg/mL of brefeldin (434 ± 139
and 489 ± 126nmol TG/mg protein with 5 and 15μg/mL of
brefeldin, resp.) compared with the control, suggesting that
secretory factors produced by macrophages contribute to TG
accumulation induced by CRLPw/o in macrophages.
3.5. Macrophage apoE Secretion and Internalization of
CRLPw/o. The absence of plasma-derived apoE in CRLPw/o
reduced but did not prevent macrophage lipid accumulation
induced by the lipid particles (Figure 2). However, apoE
is secreted in large amounts by human macrophages [23];
thus, CRLPw/o uptake could be mediated via the acquisition
of the apolipoprotein during the incubation. To test this
hypothesis, we measured the eﬀects of an apoE antibody
(apoE-Ab) on macrophage TG accumulation induced by
CRLPw/o. For this purpose, HMDM were incubated for
2 4hw i t hC R L P w / o( 8 0μg cholesterol/mL) in the presence
of 100μg/mL of apoE-Ab or control IgG isotype. The TG
contentofmacrophagesattheendofincubationswithapoE-
Ab (708.9 ± 152.6nmol/mg protein) was not diﬀerent from
incubations with IgG (842 ± 310nmol/mg protein) or in the
absence of antibody (control: 703.5 ± 213.5nmol/mg pro-
tein) (n = 3), indicating that apoE secreted by macrophages
does not account for the uptake of the apoE-free CRLPw/o.
To further ascertain whether the secretion of apoE has a
role in CRLPw/o lipid uptake, we carried out experimentsInternational Journal of Vascular Medicine 5
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Figure 3: Eﬀect of cytochalasin D and PMA on macrophage lipid accumulation. HMDM were incubated 24h with 80μg cholesterol/mL
CRLPw/oorwithoutCRLPw/ointhepresenceof2μg/mLcytochalasinD(CytD),or1μg/mLPMAbothdissolvedinDMSOorDMSOalone
(control). Macrophage triacylglycerol (TG) and total cholesterol (TCH) content (nmol lipid/mg protein) were determined by ﬂuorimetric
assay (mean ± SD, n = 4).
with J774 cells, a murine macrophage cell line which secretes
extremely low levels of apoE [24]. In control J774 macro-
phages, similar to the results with HMDM, CRLPw/o (80μg
cholesterol/mL) induced a signiﬁcant increase in TG content
(without CRLPw/o, 132.9 ± 21.9; with CRLPw/o 230.8 ±
10.9nmol/mg protein; P < 0.05, n = 3) with no signiﬁcant
change in cholesterol content. Thus, the relative lack of apoE
secretion did not prevent J774 macrophages from accumu-
lating TG in the presence of CRLPw/o, conﬁrming that apoE
is not necessary for the uptake of these particles by the cells.
3.6. Role of Proteoglycan Bridging in Lipid Accumulation
Induced by CRLPw/o. The interaction of lipoproteins with
arterial proteoglycans facilitates the retention and the
metabolism of TG-rich lipoproteins. In particular, proteins
secreted by macrophages, such as apoE, lipoprotein lipase
(LPL), and the secretory phospholipase A2 (sPLA2), inde-
pendently of their function, can act as structural cofactors
facilitating cellular uptake of whole lipoprotein particles.
These molecules can bridge between lipoproteins and hep-
aran sulfate proteoglycans, concentrating lipoproteins in the
vicinity of receptors or promoting entry of lipoproteins
during the process of cell surface proteoglycan internaliza-
tion [25, 26]. If this process was involved in CRLPw/o
internalization by macrophages, therefore, the inhibition
of the interaction with proteoglycans would be expected
to impair their uptake. To test this hypothesis, HMDM,
untreated (control) or pretreated for 1h with heparinase
I( 3 3 U / m L )[ 27] or heparinase III (33U/mL), both with
50mM Na chlorate to inhibit proteoglycan synthesis [28],
werefurtherincubated for24hwithCRLPw/o(80μgcholes-
terol/mL). As reported in Figure 4, a rise (rather than a
decrease) in TG content was induced by both heparinase
III and heparinase I (586 ± 71 and 539 ± 58nmol/mg
protein, resp.) in comparison with the control group (445 ±
64nmol/mg protein). Thus, the disruption of cell surface
proteoglycans with heparinase did not decrease CRLP TG
uptake by macrophages, indicating that the function of LPL,
and other secreted proteins in bridging with proteoglycan is
not involved in CRLPw/o internalization by macrophages.
3.7.RoleofMacrophageLipaseActivitiesontheInternalization
of TG Carried by CRLPw/o. The experiments above show
that CRLPw/o induces the accumulation of TG but do
not provide information about the mechanism involved.
However, the data obtained with brefeldin suggests that
macrophage-secreted factors may function in CRLPw/o
TG uptake. Among the proteins secreted by macrophages,
there are a number of lipases, including LPL, sPLA2,a n d
cholesteryl ester hydrolase [29–32]. Secreted LPL has been
shown to have an important function in the uptake of fatty
acids derived from the extracellular lipolysis of TG carried
by TG-rich lipoproteins [29]. In view of this, we examined
whether the lipases produced by macrophages contribute
to TG uptake from CRLPw/o. Macrophage sPLA2 cleave
phospholipid (PL) fatty acids in the sn-2 position [31],
and, while fatty acids released by cholesteryl ester hydrolase
secreted by macrophages derive mainly from cholesteryl
ester, TG and PL may also function as substrates [31]. The
fatty acids liberated by the catalytic action of extracellular
lipase, however, could supply substrate for cellular TG
synthesis, even without internalization of whole CRLPw/o.
Alternatively, fatty acids released by these lipases could
occur after the internalization of CRLPw/o. In order to
evaluate whether macrophage lipolytic activities contribute
to the internalization of intact TG carried by CRLPw/o,
we used an experimental approach involving radiolabelled6 International Journal of Vascular Medicine
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Figure 4: Role of proteoglycan-mediated bridging in macrophage lipid accumulation. HMDM were incubated 1h in serum-free medium
before treatment with 33U/mL heparinase III (Hep III) or 33U/mL heparinase I (Hep I) in combination with 50mM Na chlorate. Both
untreated and treated macrophages were then incubated 24h with 80μg cholesterol/mL CRLPw/o. Treatments were continued during the
incubations. Macrophage triacylglycerol (TG) and total cholesterol (TCH) contents are reported as nmol/mg protein (means ± SD, n = 4).
∗P < 0.005 versus control.
CRLPw/o particles. HMDM were incubated with [3H]TG-
CRLPw/o (80μg cholesterol/mL) in the presence of diﬀerent
lipase inhibitors, and cell incorporation of CRLPw/o lipid
was evaluated by measuring the radioactivity recovered
in macrophage lipids. To inhibit cholesteryl ester hydro-
lase, LPL and sPLA2, way121.989 [33], orlistat [34], and
manoalide [35], respectively, were used. After incorporation
into macrophages, radioactivity transported by [3H]TG is
redistributed into cellular fatty acids. To assess this, at
the end of incubations with [3H]TG-CRLPw/o, lipids were
extracted from the cells and the radioactivity associated
with TG, PL, free fatty acids, and cholesteryl esters was
determined [7]. Most of the radioactivity was found in
macrophage [3H]TG and, much less, about 1/10, was in
the [3H]PL fraction. The radioactivity associated with free
fatty acids and cholesteryl esters was negligible and was
not taken into account in further analysis of the data.
Thus, the total radioactivity taken up by macrophages was
calculated as the sum of [3H]TG + [3H]PL. The results are
shown in Figure 5. None of the inhibitors had any signiﬁ-
cant eﬀect on the incorporation of radioactivity into PL
(central panel), although all of them tended to decrease
the total radioactivity taken up by macrophages, compared
with macrophages incubated without inhibitors (control).
However, the reductions were signiﬁcant in comparison to
the control only for manoalide (P < 0.05 and P < 0.001
at 0.2 and 2μMo fm a n o a l i d e ,r e s p e c t i v e l y ;n = 3) and
for the higher concentration (2μM) of orlistat (P<0.05;
n = 3). The decreased total radioactivity incorporated by
macrophages treated with both concentrations of manoalide
reﬂected the lower macrophage accumulation of [3H]TG
(upper panel) in these conditions, in comparison with either
the control or way121.989. Thus, the internalization of TG
carried by CRLPw/o is mainly dependent on sPLA2 activity,
but not cholesteryl ester hydrolase or LPL.
3.8. Role of Lipase Activities in TG and PL Synthesis after
Uptake of CRLP by Macrophage. To assess how lipases aﬀect
lipidsynthesisinHMDMafteruptakeofCRLPw/o,cellswere
preincubated for 2h with or without inhibitors of sPLA2
(MJ33 10μM), cytosolic PLA2 (MAFP, 5μMa n d1 0 μM)
[36], calcium-dependent cytosolic PLA2 (HELSS, 5μM) [37]
and LPL (orlistat, 2μM). Incubation was then continued for
5h in the presence of CRLPw/o (80μg cholesterol/mL) to
evaluate the incorporation of [3H]glycerol into TG and PL
(Figure 6).
PL synthesis was not signiﬁcantly aﬀected by any of the
inhibitors tested (data not shown), but HELSS and MAFP at
a concentration of 10μM were found to inhibit TG synthesis
(P < 0.05), while orlistat, MJ33, and 5μMM A F Ph a dn o
signiﬁcant eﬀect. These results suggest that cytosolic and
calcium-dependent PLA2,b u tn o ts P L A 2 or LPL, play a partInternational Journal of Vascular Medicine 7
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Figure 5: Role of macrophage-secreted lipases on [3H]TG-CRLPw/o internalization. Cell radioactivity associated with macrophage lipids
was determined after a 6-h incubation of HMDM with 80μg cholesterol/mL of [3H]TG-CRLPw/o in the presence of 10 and 30μM
way121.989 (way), 0.2 and 2μM of manoalide, 0.2 and 2μM of orlistat or in the absence of any inhibitor (control). Radioactivity associated
with free fatty acids and cholesteryl ester was negligible, and that associated with macrophage triacylglycerol ([3H]TG, (a)), phospholipid
([3H]PL, (b)), and [3H](TG+PL) (c) is reported as nmol/h/mg protein (n = 3). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 versus control; #P <
0.05, ##P < 0.01 versus manoalide 2μM.
in the regulation of TG synthesis after uptake of CRLPw/o by
human macrophages.
4. Discussion
Chylomicron remnants can induce TG accumulation and
foam cell formation [7–10]; however, the interactions
between these postprandial lipoproteins and macrophages
are poorly understood. Much evidence suggests that both
receptor-dependent and -independent mechanisms function
in lipid accumulation, as apolipoproteins may not be neces-
s a r yf o rr e c e p t o ri n t e r a c t i o n[ 6, 38] or induction of macro-
phage lipid accumulation [6, 12, 39]. However, studies and
manipulation with chylomicron remnants are methodologi-
cally limited. There are marked diﬃculties in the preparation
of postprandial lipoprotein fractions not contaminated by
other lipoproteins. Thus, although studies performed with
lipoprotein models devoid of apolipo-proteins may not
reproduce physiological conditions, these models help to
clarify the apolipoprotein receptor-independent mecha-
nisms, which contribute in vivo to the accumulation of lipids
inthevesselwall.Wefocusedthecurrentinvestigationonthe
mechanisms of internalization involved in lipid accumula-
tion caused by apolipoprotein-free CRLPw/o. Macrophages
are now known to have both pro- and anti-inﬂammatory
properties; inﬂammation is essential for protection against
pathogens, but healing requires the deleterious eﬀects on
the tissues to be suppressed. This dual role is facilitated by
alternative activation of the cells into a pro- (M1) or anti-
inﬂammatory (M2) phenotype [40]. Since our macrophage
model is obtained in vitro in the absence of any stimulus,
taking into account the limitations of a cell model, we believe
it resembles more closely the classically polarized, round-
shaped activated M1 macrophages.8 International Journal of Vascular Medicine
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Figure 6: Role of macrophage lipase activities in TG synthesis.
HMDM were preincubated for 2h with or without 10μM MJ33,
5μMa n d1 0 μMM A F P[ 36], 5μM HELSS, and 2μMo r l i s t a t .
Incubation was then continued for 5h in presence of CRLPw/o
(80μg cholesterol/mL) in the presence of [3H]glycerol (4μCi/mL,
20μM) to evaluate the incorporation of [3H]glycerol into TG.
Radioactivity associated with triacylglycerol ([3H]TG) is reported
as nmol/h/mg protein (n = 3). ∗P < 0.05 versus control.
Macrophages are now known to have both pro- and
anti-inﬂammatory properties; inﬂammation is essential for
protection against pathogens, but healing requires the dele-
terious eﬀects on the tissues to be suppressed. This dual role
is facilitated by alternative activation of the cells into a pro-
(M1) or anti-inﬂammatory (M2) phenotype [40]. Since our
macrophage model is obtained in vitro in the absence of any
stimulus, taking into account the limitations of a cell model,
we believe it resembles more closely the classically polarized,
round-shaped activated M1 macrophages.
We found that the incubation of CRLPw/o with plasma
inducessomechangesincompositionsoftheselipidparticles
including the acquisition of apolipoproteins [11], as well as
the decrease of change of the ratios TG/TCH and FCH/TCH
(Table 1). Despite their similar TG concentrations, CRLPw/o
contain less TCH with a larger proportion of FCH (about
50%), which probably functions to stabilize the surface of
these particles devoid of apolipoproteins. Thus, in compar-
ison with CRLP+, CRLPw/o are larger buoyant particles
(Figure 1), stabilized at their surface by a higher number of
FCH molecules.
The lack of apolipoproteins on CRLPw/o did not prevent
a signiﬁcant increase of TG in both HMDM and J774
cell line macrophages during incubation with CRLPw/o.
CRLPw/o induced TG accumulation independently of both
phagocytosis and macropinocytosis. Macropinocytosis and
phagocytosis are related but independent actin-dependent
processes functioning in macrophages [19]a n dc a nc o n -
tribute to foam cell formation by facilitating lipid accumu-
lation. In particular, macropinocytosis, which functions in
uptake of particles in the ﬂuid phase, has been shown to
mediate the induction of foam cell formation by LDL [20].
However, macropinocytosis is particularly eﬃc i e n ta th i g h
levels of lipoprotein that could not be achieved with CRLP
in the current investigation due to experimental limitations.
Chylomicron remnants are specialized to transport high
quantities of TG, which at elevated concentrations induce
cell detachment and toxicity [6, 41, 42]. We also found that
CRLPw/o induce slight cell detachment at a concentration
higher than 80μg cholesterol/mL (data not shown). Thus, in
our experimental conditions, conclusions about the lack of
a role of macropinocytosis and phagocytosis involvement in
CRLP processing are limited to the concentrations that we
were able to test.
A possible mechanism for macrophage uptake of
CRLPw/o is that they acquire macrophage-secreted apoE,
which could lead to whole lipid particle uptake mediated
by macrophage apoE-dependent receptors [43]. However,
an anti-apoE antibody had no eﬀect on TG accumulation
induced by CRLPw/o in HMDM, suggesting that apoE is
not necessary for CRLPw/o-mediated lipid accumulation in
these cells and this conclusion was supported by the ﬁnding
that CRLPw/o induced TG accumulation in J774 macro-
phages, a murine cell line which does not secrete apoE
[24]. These results are in agreement with the observations
of Fujioka et al. [6], who found that macrophages from
apoE-deﬁcient mice internalize apolipoprotein-free remnant
particles.
LPL and PLA2,a sw e l la sa p o Es e c r e t e db ym a c r o p h a g e s ,
contribute to lipoprotein processing by acting as bridges
between lipoproteins and heparan sulfate proteoglycans [25,
26]. However, our experiments exclude the possibility that
extracellularlipasesorotherproteins thatmayactinthisway
are involved in macrophage CRLPw/o processing. Treatment
with either heparinase I or heparinase III, which cause a
loss of surface proteoglycans, increased CRLPw/o-induced
macrophage TG accumulation (Figure 4), suggesting that
surface proteoglycans may hinder rather than promote
macrophage uptake of CRLPw/o.
The observation that the inhibition of macrophage
secretion by brefeldin decreases CRLPw/o induced TG accu-
mulation (Figure 3) focused our attention on macrophage
secretory products. Although impairment of proteoglycans,
apoE or LPL functions did not prevent TG accumulation,
the inhibition of sPLA2 markedly reduced the internal-
ization of CRLPw/o, indicating a role for this enzyme in
the metabolism of TG-rich lipoproteins. As the free fatty
acids released after extracellular lipolysis enter cells and
are re-esteriﬁed, contributing to an increase in cell TG
content, we expected that the LPL inhibitor orlistat would
cause a reduction in cellular TG accumulation induced
by CRLPw/o. Surprisingly, in contrast to what has been
reported for VLDL and chylomicron remnants [13, 29, 43],
theexperimentswithradiolabelledparticlesshowedthatLPL
is not a major factor involved in the uptake of [3H]TG in
CRLP devoid of apolipoproteins. The higher concentration
of orlistat decreased the internalization of the [3H]TG-
CRLPw/o(−29%)onlywhenthetotallipidradioactivitywas
takenintoaccount(Figure 5(c)),whilethechangesinmacro-
phage [3H]TG were not signiﬁcant. On the other hand, the
inhibition of sPLA2 activity by manoalide reduced in theInternational Journal of Vascular Medicine 9
incorporation of radioactivity into cellular [3H]TG as well
as the total lipid radioactivity in a dose-dependent manner.
The inhibition of [3H]TG-CRLP accumulation by HMDM
induced by 0.5μMa n d2 μM of this inhibitor was about
32 and 45%, respectively, showing that, in contrast to LPL
action, the catalytic activity of sPLA2 has a prominent role
in macrophage accumulation of TG during incubation with
CRLPw/o.
This observation adds further details to the complex
picture of the role of sPLA2 in the development of car-
diovascular disease. The current opinion is that circulating
members of the PLA2 family are positively associated with
the pathogenesis of atherosclerosis by diﬀerent mechanisms,
including the generation of atherogenic particles [44], as
well as the activation of several proinﬂammatory pathways
[45] .S e v e r a lp h y s i o l o g i c a la c t i o n so fs P L A 2 are unrelated
to their enzymatic activity; rather, they can be attributed
to the engagement of speciﬁc receptors on target cells [46].
However, in this study, the hypothesis that manoalide inﬂu-
ences [3H]TG-CRLPw/o metabolism by interfering with the
speciﬁcbindingofsPLA2 toasurfacereceptorseemsunlikely,
because the manoalide binds irreversibly to several lysine
residues of the enzyme, inhibiting speciﬁcally its activity
[35]. Furthermore, the macrophage sPLA2 subtypes com-
prise a diverse family of enzymes that catalyze the hydrolysis
ofthesn-2esterbond ofPLandglycerophospholipids butdo
not act on TG [31, 47, 48]. Thus, the eﬀects of manoalide on
cell [3H]TGrecovery,incontrasttoLPL,cannotbeexplained
in terms of massive extracellular TG hydrolysis followed by
intracellularre-esteriﬁcation.Inaddition,astheradioactivity
was speciﬁcally carried by [3H]TG in CRLPw/o, extracellular
hydrolysis of PL did not contribute to the macrophage
accumulation of [3H]TG observed in our study. However,
since the particles contain 70% TG and 25% PL (of which
about 85% can be substrates of PLA2), and TG contains 3
fatty acids that can be hydrolyzed and re-esteriﬁed, while
PL contain only 2 fatty acids (with only 1 hydrolyzable
by PLA2), about 1/10 of the fatty that can be re-esteriﬁed
are in the PL and 9/10 in the TG. Thus, the ﬁnding that,
after uptake of the radiolabelled CRLPw/o, approximately
1/10 of the radioactivity is found in phospholipids suggests
that the whole particles are taken up by the cells and that
phospholipids are then hydrolyzed and re-esteriﬁed. Overall,
our results indicate that sPLA2 activity could contribute
to CRLPw/o lipid internalization by inducing lipoprotein
modiﬁcations which, in turn, increase the catabolism of
the whole particle and/or selectively facilitate uptake of the
TG moiety. For instance, Tietge et al. [49] reported that
overexpression of sPLA2 enzymatic activity alters the struc-
ture and composition of high-density lipoprotein (HDL)
particles, enhancing selective uptake of cholesteryl ester with
the metabolic consequences of increased catabolism of HDL.
Similarly, some changes to CRLPw/o induced by the catalytic
activity of sPLA2 could expose or hide domains in the
particles, which then could facilitate macrophage uptake
of the TG carried by CRLPw/o. More studies are needed,
however, to substantiate this idea.
Although our data indicate a role for sPLA2 in the
internalizationofCRLPw/o,theinhibitionoftheenzymedid
not aﬀect the synthesis of TG from glycerol in HMDM after
uptake of the particles (Figure 6). Interestingly, however, the
results of this set of experiments indicate the involvement
of cytoplasmatic PLA2 and in particular of Ca2+-dependent
PLA2 in macrophage CRLPw/o metabolism. As MAFP
is an irreversible inhibitor of of both calcium-dependent
and calcium-independent cytosolic phospholipase A2,b u t
not secretory phospholipase A2 [36], the ﬁnding that TG
synthesis was decreased in the presence of this inhibitor
supports the hypothesis that cytosolic PLA2 activity plays a
roleinCRLPw/oprocessing.Inparticular,ourresultsdirectly
implicate the Ca2+-dependent PLA2 activity, since HELSS, a
direct and irreversible inhibitor of this enzyme [37], reduced
thesynthesisofTGinducedbyCRLPw/oinasimilarmanner
to MAFP (Figure 6).
In conclusion, this study shows that sPLA2 plays a role
in the extensive macrophage TG accumulation promoted
by TG-rich chylomicron remnant-like lipoproteins. Fur-
thermore, this macrophage TG accumulation occurs inde-
pendently of apolipoprotein-mediated receptor interactions,
supportingtheconceptthatmoreattentionshouldbepaidto
pathways for macrophage lipid internalization not mediated
by apolipoprotein-receptor interactions.
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